FH Australasia Network

FHAN logo

Familial hypercholesterolaemia (FH) is a dominantly inherited disorder present from birth that markedly elevates plasma low-density lipoprotein (LDL) cholesterol and causes premature coronary heart disease. There are at least 20 million people with FH worldwide, but the majority remain undetected and current treatment is often suboptimal.

The mission of the FH Australasia Network is to prevent early heart attacks in people with inherited high cholesterol by means of:

  • identification, diagnosis and treatment of genetic cholesterol disorders for patients and their affected relatives
  • educating patients, health care providers and government agencies
  • fostering patient support
  • encouraging research to increase understanding and treatment of genetic cholesterol disorders
  • promoting public health efforts fostering collaboration between agencies and other health care providers

The FH Australasia Network is managed by the AAS Familial Hypercholesterolaemia Sub-Committee and is a dedicated team of clinicians and scientists from around Australia and New Zealand. Activities currently underway include the development of management guidelines, information sessions for clinicians and the establishment of various services around the country.

Terms of Use I Privacy Policy I Disclaimer